Status:
COMPLETED
Curcumin Gel On Radiation Induced Oral Mucositis
Lead Sponsor:
University of Baghdad
Conditions:
Radiation-Induced Mucositis
Head and Neck Cancer
Eligibility:
All Genders
16-80 years
Phase:
NA
Brief Summary
The goal of this clinical study is to investigate the effect of a curcuma longa oral gel (curenext) on reducing radiation-induced oral mucositis severity in cancer patients and provide a context for u...
Eligibility Criteria
Inclusion
- Patients above 16 years having histopathologically confirmed cancer in head and neck region who planned to have radiation with head and neck mask.
- Scheduled for 6-8 weeks of radiotherapy with 60-70Gy radiation (200cgy/fraction for 5 days/week).
Exclusion
- patient with hodgkin lymphoma.
- Any allergy to curcumin or other condiments.
Key Trial Info
Start Date :
January 3 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 2 2023
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05982197
Start Date
January 3 2023
End Date
July 2 2023
Last Update
August 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nuclear medicine and radiation therapy hospital
Baghdad, Iraq, 10053